Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Non Erosive Reflux Disease
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the superiority of efficacy of CJ-12420, once
daily (QD), compared to placebo in patients with non-erosive reflux disease at Week 4